These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 23469913
1. Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes. Alonso R, Mata P, Zambón D, Mata N, Fuentes-Jiménez F. Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):327-42. PubMed ID: 23469913 [Abstract] [Full Text] [Related]
9. Novel treatments for familial hypercholesterolemia: pharmacogenetics at work. Marbach JA, McKeon JL, Ross JL, Duffy D. Pharmacotherapy; 2014 Sep; 34(9):961-72. PubMed ID: 24899514 [Abstract] [Full Text] [Related]
10. NLA Symposium screening and treatment of familial hypercholesterolemia: how can we do better? Opening and introductions. McGowan M. J Clin Lipidol; 2010 Sep; 4(5):335-7. PubMed ID: 21122673 [Abstract] [Full Text] [Related]
11. Modern Management of Familial Hypercholesterolemia. Duell PB, Jialal I. Metab Syndr Relat Disord; 2016 Dec; 14(10):463-467. PubMed ID: 27797643 [Abstract] [Full Text] [Related]
12. Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017. Harada-Shiba M, Arai H, Ishigaki Y, Ishibashi S, Okamura T, Ogura M, Dobashi K, Nohara A, Bujo H, Miyauchi K, Yamashita S, Yokote K, Working Group by Japan Atherosclerosis Society for Making Guidance of Familial Hypercholesterolemia. J Atheroscler Thromb; 2018 Aug 01; 25(8):751-770. PubMed ID: 29877295 [Abstract] [Full Text] [Related]
15. Management of patients with familial hypercholesterolaemia. Reiner Ž. Nat Rev Cardiol; 2015 Oct 01; 12(10):565-75. PubMed ID: 26076948 [Abstract] [Full Text] [Related]
16. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group. Am Heart J; 2004 Sep 01; 148(3):447-55. PubMed ID: 15389231 [Abstract] [Full Text] [Related]
17. Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades. Elis A, Zhou R, Stein EA. Am J Cardiol; 2011 Jul 15; 108(2):223-6. PubMed ID: 21545982 [Abstract] [Full Text] [Related]
20. Familial hypercholesterolaemia: a model of care for Australasia. Watts GF, Sullivan DR, Poplawski N, van Bockxmeer F, Hamilton-Craig I, Clifton PM, O'Brien R, Bishop W, George P, Barter PJ, Bates T, Burnett JR, Coakley J, Davidson P, Emery J, Martin A, Farid W, Freeman L, Geelhoed E, Juniper A, Kidd A, Kostner K, Krass I, Livingston M, Maxwell S, O'Leary P, Owaimrin A, Redgrave TG, Reid N, Southwell L, Suthers G, Tonkin A, Towler S, Trent R, Familial Hypercholesterolaemia Australasia Network Consensus Group (Australian Atherosclerosis Society). Atheroscler Suppl; 2011 Oct 15; 12(2):221-63. PubMed ID: 21917530 [Abstract] [Full Text] [Related] Page: [Next] [New Search]